NCT03493945 2025-09-30Phase I/II Study of Immunotherapy Combination BN-Brachyury Vaccine, M7824, N-803 and Epacadostat (QuEST1)National Institutes of Health Clinical Center (CC)Phase 1/2 Completed59 enrolled 20 charts
NCT03374488 2025-08-22Pembrolizumab + Epacadostat vs Pembrolizumab + Placebo in Recurrent or Progressive Metastatic Urothelial CarcinomaIncyte CorporationPhase 3 Completed84 enrolled 13 charts
NCT03260894 2025-07-29Pembrolizumab (MK-3475) Plus Epacadostat vs Standard of Care in mRCC (KEYNOTE-679/ECHO-302)Incyte CorporationPhase 3 Completed129 enrolled 13 charts